United States Biopsy Devices Market Forecast 2024-2032
KEY FINDINGS
The United States biopsy devices market is projected to grow at a CAGR of 7.79% over the forecast years. While the base year considered for the market is 2023, the forecast period is from 2024 to 2032. The market growth is boosted by various factors, comprising the rising prevalence of cancer, increasing demand for minimally invasive surgeries, and a surge in the number of hospitals and diagnostic centers.
MARKET INSIGHTS
The elevation in the United States biopsy devices market is powered by increased healthcare spending, indicating a commitment to investing in advanced medical technologies, particularly biopsy devices. This financial support is improving accessibility to advanced biopsy solutions, leading to enhanced diagnostic capabilities and better healthcare outcomes nationwide. A preeminent trend shaping the market is the shift towards preventive healthcare, aligning with the national focus on early detection and disease prevention.
Biopsy devices are vital in this preventive approach, facilitating timely identification and intervention. The emphasis on preventive healthcare positions biopsy devices as essential tools in advancing public health initiatives and reducing the overall burden of diseases in the United States. The market's momentum is further fueled by expanding applications across medical specialties. Consequently, these factors are expected to foster the market's growth in the United States during the forecast period.
COMPETITIVE INSIGHTS
Some of the major companies in the United States biopsy devices market include Argon Medical Devices, Cardinal Health, Boston Scientific, Hologic Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Methodology
- 1.3. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Country Snapshot
- 2.3. Country Analysis
- 2.4. Scope Of Study
- 2.5. Crisis Scenario Analysis
- 2.5.1. Impact Of Covid-19 On Biopsy Devices Market
- 2.6. Major Market Findings
- 2.6.1. Growing Emphasis On Personalized Medicine
- 2.6.2. Expanding Applications Across Medical Specialities
- 2.6.3. Development Of Cost-effective Biopsy Solutions
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Rising Prevalence Of Cancer
- 3.1.2. Increasing Demand For Minimally Invasive Surgeries
- 3.1.3. Surge In The Number Of Hospitals And Diagnostic Centers
- 3.2. Key Restraints
- 3.2.1. High Risk Of Infection For Patients
- 3.2.2. High Cost Of Biopsy Procedures
- 3.2.3. Lack Of Skilled Professionals
- 4. Key Analytics
- 4.1. Key Market Trends
- 4.1.1. Surge In The Healthcare Expenditure
- 4.1.2. Shift Towards Preventive Healthcare
- 4.1.3. Advancements In Biopsy Technology
- 4.2. Pestle Analysis
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitutions
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Value Chain Analysis
- 4.4.1. Raw Materials
- 4.4.2. Manufacturers
- 4.4.3. Distribution
- 4.4.4. End-users
- 5. Market By Product
- 5.1. Needle- Based Biopsy Guns
- 5.1.1. Vacuum-assisted Biopsy (Vab) Devices
- 5.1.2. Fine Needle Aspiration Biopsy (Fnab) Devices
- 5.1.3. Core Needle Biopsy (Cnb) Devices
- 5.2. Biopsy Guidance Systems
- 5.3. Biopsy Needles
- 5.4. Biopsy Forceps
- 5.5. Other Products
- 6. Market By Application
- 6.1. Oncology
- 6.2. Gastroenterology
- 6.3. Pulmonology
- 6.4. Dermatology
- 6.5. Other Applications
- 7. Market By End Use
- 7.1. Hospitals
- 7.2. Ambulatory Surgical Centers
- 7.3. Diagnostic Centers
- 8. Competitive Landscape
- 8.1. Key Strategic Developments
- 8.1.1. Mergers & Acquisitions
- 8.1.2. Product Launches & Developments
- 8.1.3. Partnerships & Agreements
- 8.1.4. Business Expansions & Divestitures
- 8.2. Company Profiles
- 8.2.1. Cardinal Health
- 8.2.2. Hologic Inc
- 8.2.3. Danaher Corporation
- 8.2.4. Conmed Corporation
- 8.2.5. Cook Medical
- 8.2.6. Dtr Medical
- 8.2.7. Inrad Inc
- 8.2.8. Boston Scientific
- 8.2.9. Becton Dickinson And Company
- 8.2.10. Argon Medical Devices
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook